메뉴 건너뛰기




Volumn 11, Issue 5, 2009, Pages 1115-1125

Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil

Author keywords

5 fluorouracil; Bola surfactant; Breast cancer cells; Colloidal drug delivery; Niosomes; Xenograft tumor

Indexed keywords

5-FLUOROURACIL; BOLA-SURFACTANT; BREAST CANCER CELLS; COLLOIDAL DRUG DELIVERY; NIOSOMES;

EID: 70549095825     PISSN: 13872176     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10544-009-9328-2     Document Type: Article
Times cited : (95)

References (38)
  • 6
    • 0032819868 scopus 로고    scopus 로고
    • Locally advanced breast cancer: The outcome of primary polychemotherapy based on infusional 5 fluorouracil
    • DOI 10.1054/brst.1999.0049
    • K Davidson DA Cameron P Dillon A Bowman M Stewart RCF Leonard 1999 The Breast 8 110 10.1054/brst.1999.0049 (Pubitemid 29450256)
    • (1999) Breast , vol.8 , Issue.3 , pp. 110-115
    • Davidson, K.1    Cameron, D.A.2    Dillon, P.3    Bowman, A.4    Stewart, M.5    Leonard, R.C.F.6
  • 11
    • 33749121585 scopus 로고    scopus 로고
    • Pharmacokinetic consequences of pegylation
    • DOI 10.1080/10717540600814402, PII L73M123363485K54
    • M Hamidi A Azadi P Rafiei 2006 Drug Delivery 13 399 10.1080/ 10717540600814402 (Pubitemid 44470219)
    • (2006) Drug Delivery , vol.13 , Issue.6 , pp. 399-409
    • Hamidi, M.1    Azadi, A.2    Rafiei, P.3
  • 15
    • 24744448887 scopus 로고    scopus 로고
    • Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B
    • DOI 10.1016/j.imlet.2005.04.002, PII S0165247805000994
    • S Jain P Singh V Mishra SP Vyas 2005 Immunol. Lett. 101 41 10.1016/j.imlet.2005.04.002 (Pubitemid 41297497)
    • (2005) Immunology Letters , vol.101 , Issue.1 , pp. 41-49
    • Jain, S.1    Singh, P.2    Mishra, V.3    Vyas, S.P.4
  • 16
    • 16544371356 scopus 로고    scopus 로고
    • Evaluation of cell death caused by CDF (cyclophosphamide, doxorubicin, 5-fluorouracil) multi-drug administration in the human breast cancer cell line MCF-7
    • DOI 10.1248/bpb.27.392
    • F Kugawa A Ueno M Kawasaki M Aoki 2004 Biol. Pharm. Bull. 27 392 10.1248/bpb.27.392 (Pubitemid 41685485)
    • (2004) Biological and Pharmaceutical Bulletin , vol.27 , Issue.3 , pp. 392-398
    • Kugawa, F.1    Ueno, A.2    Kawasaki, M.3    Aoki, M.4
  • 17
    • 14844303778 scopus 로고    scopus 로고
    • Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
    • DOI 10.1016/j.jconrel.2004.12.018, PII S0168365904006273
    • ES Lee K Na YH Bae 2005 J. Control. Rel. 103 405 10.1016/j.jconrel.2004. 12.018 (Pubitemid 40342538)
    • (2005) Journal of Controlled Release , vol.103 , Issue.2 , pp. 405-418
    • Lee, E.S.1    Na, K.2    Bae, Y.H.3
  • 18
    • 0032801125 scopus 로고    scopus 로고
    • A pilot study of continuous infusional 5-fluorouracil, doxorubicin and cyclophosphamide in breast cancer
    • DOI 10.1053/clon.1999.9036
    • HJ Mackay D Bissett C Twelves PA Vasey 1999 Clin. Oncol. 11 174 10.1053/clon.1999.9036 (Pubitemid 29366589)
    • (1999) Clinical Oncology , vol.11 , Issue.3 , pp. 174-178
    • Mackay, H.J.1    Bissett, D.2    Twelves, C.3    Vasey, P.A.4
  • 19
    • 18644361997 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
    • DOI 10.2165/00003088-200544040-00001
    • I Mahmood MD Green 2005 Clin. Pharmacokinet. 44 331 10.2165/00003088- 200544040-00001 (Pubitemid 40663681)
    • (2005) Clinical Pharmacokinetics , vol.44 , Issue.4 , pp. 331-347
    • Mahmood, I.1    Green, M.D.2
  • 20
    • 33644627637 scopus 로고    scopus 로고
    • Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin
    • DOI 10.1016/j.ijpharm.2005.11.045, PII S0378517305008586
    • M Manconi C Sinico D Valenti F Lai AM Fadda 2006 Int. J. Pharm. 311 11 10.1016/j.ijpharm.2005.11.045 (Pubitemid 43319196)
    • (2006) International Journal of Pharmaceutics , vol.311 , Issue.1-2 , pp. 11-19
    • Manconi, M.1    Sinico, C.2    Valenti, D.3    Lai, F.4    Fadda, A.M.5
  • 21
    • 0032824375 scopus 로고    scopus 로고
    • Possibility of active targeting to tumor tissues with liposomes
    • DOI 10.1016/S0169-409X(99)00042-3, PII S0169409X99000423
    • K Maruyama O Ishida T Takizawa K Moribe 1999 Adv. Drug Deliv. Rev. 40 89 10.1016/S0169-409X(99)00042-3 (Pubitemid 29486606)
    • (1999) Advanced Drug Delivery Reviews , vol.40 , Issue.1-2 , pp. 89-102
    • Maruyama, K.1    Ishida, O.2    Takizawa, T.3    Moribe, K.4
  • 24
    • 0032866761 scopus 로고    scopus 로고
    • The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs
    • DOI 10.1016/S0169-409X(99)00041-1, PII S0169409X99000411
    • A Nagayasu K Uchiyama H Kiwada 1999 Adv. Drug Deliv. Rev. 40 75 10.1016/S0169-409X(99)00041-1 (Pubitemid 29486605)
    • (1999) Advanced Drug Delivery Reviews , vol.40 , Issue.1-2 , pp. 75-87
    • Nagayasu, A.1    Uchiyama, K.2    Kiwada, H.3
  • 25
    • 23444457781 scopus 로고    scopus 로고
    • Effect of cholesterol and temperature on the elastic properties of niosomal membranes
    • DOI 10.1016/j.ijpharm.2005.05.009, PII S0378517305003170
    • B Nasseri 2005 Int. J. Pharm. 300 95 10.1016/j.ijpharm.2005.05.009 (Pubitemid 41112171)
    • (2005) International Journal of Pharmaceutics , vol.300 , Issue.1-2 , pp. 95-101
    • Nasseri, B.1
  • 26
    • 0037462992 scopus 로고    scopus 로고
    • PEGylated nanoparticles for biological and pharmaceutical applications
    • DOI 10.1016/S0169-409X(02)00226-0
    • H Otsuka Y Nagasaki K Kataoka 2003 Adv. Drug Deliv. Rev. 55 403 10.1016/S0169-409X(02)00226-0 (Pubitemid 36293792)
    • (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.3 , pp. 403-419
    • Otsuka, H.1    Nagasaki, Y.2    Kataoka, K.3
  • 35
    • 0032531663 scopus 로고    scopus 로고
    • Non-ionic surfactant based vesicles (niosomes) in drug delivery
    • DOI 10.1016/S0378-5173(98)00169-0, PII S0378517398001690
    • IF Uchegbu PS Vyas 1998 Int. J. Pharm. 172 33 10.1016/S0378-5173(98) 00169-0 (Pubitemid 28430243)
    • (1998) International Journal of Pharmaceutics , vol.172 , Issue.1-2 , pp. 33-70
    • Uchegbu, I.F.1    Vyas, S.P.2
  • 36
    • 0029360756 scopus 로고
    • 10.1016/0169-409X(95)00028-6
    • MC Woodle 1995 Adv. Drug Del. Rev. 16 249 10.1016/0169-409X(95)00028-6
    • (1995) Adv. Drug Del. Rev. , vol.16 , pp. 249
    • Woodle, M.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.